Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Cash from Discontinued Operations: 2010-2013

Historic Cash from Discontinued Operations for Arrowhead Pharmaceuticals (ARWR) over the last 4 years, with Sep 2013 value amounting to -$354.

  • Arrowhead Pharmaceuticals' Cash from Discontinued Operations changed negligibly% to -$46.9 million in Q1 2014 from the same period last year, while for Mar 2014 it was -$187.6 million, marking a year-over-year decrease of 33.33%. This contributed to the annual value of -$354 for FY2013, which is 26.43% down from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Cash from Discontinued Operations of -$354 as of FY2013, which was down 26.43% from -$280 recorded in FY2012.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Cash from Discontinued Operations peaked at $2.3 million during FY2011, and registered a low of -$2.6 million during FY2010.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Cash from Discontinued Operations value was -$280 (recorded in 2012), while the average stood at $754,883.
  • In the last 5 years, Arrowhead Pharmaceuticals' Cash from Discontinued Operations surged by 185.62% in 2011 and then tumbled by 100.01% in 2012.
  • Yearly analysis of 4 years shows Arrowhead Pharmaceuticals' Cash from Discontinued Operations stood at -$2.6 million in 2010, then skyrocketed by 185.62% to $2.3 million in 2011, then plummeted by 100.01% to -$280 in 2012, then decreased by 26.43% to -$354 in 2013.